FDA expedites Osiris Therapeutics' Crohn's disease treatment
Mon, 08 Jan 2007 11:05 PM EST
... (Reuters) - Osiris Therapeutics Inc. said it received fast track status from U.S. regulators for its stem cell therapy, Prochymal, to treat Crohn's Disease that does not respond to standard therapies. ...
Related Topics
- Crohn's Disease
- Pharmacology
- Periodontal Disease
- Vascular Disease
- Addison's Disease
- Heart Disease
- Huntington's Disease
- Gum Disease
- Kidney Disease
- Autoimmune Diseases
- Graves' Disease
- Cardiovascular Diseases And Disorders
- Parkinson's Disease
- Liver Disease
- Diseases & Conditions
- Alzheimer's Disease
- Coronary Artery Disease
- Hodgkin's Disease
- Meniere's Disease
- Coronary Artery Diseases

Not Signed In -


